Empowered Funds LLC trimmed its holdings in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 73.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,976 shares of the business services provider's stock after selling 94,386 shares during the period. Empowered Funds LLC owned about 0.10% of Cross Country Healthcare worth $617,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Truvestments Capital LLC purchased a new position in Cross Country Healthcare in the 3rd quarter valued at approximately $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Cross Country Healthcare during the 3rd quarter valued at $49,000. Point72 DIFC Ltd acquired a new stake in Cross Country Healthcare during the 3rd quarter valued at $52,000. Gladius Capital Management LP grew its holdings in Cross Country Healthcare by 83.4% during the 3rd quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider's stock valued at $54,000 after buying an additional 1,812 shares during the last quarter. Finally, US Bancorp DE grew its holdings in Cross Country Healthcare by 10,909.3% during the 3rd quarter. US Bancorp DE now owns 4,734 shares of the business services provider's stock valued at $64,000 after buying an additional 4,691 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.
Cross Country Healthcare Stock Performance
Shares of CCRN traded up $0.05 during trading hours on Friday, hitting $18.10. The stock had a trading volume of 566,525 shares, compared to its average volume of 426,786. The company's fifty day simple moving average is $18.13 and its 200 day simple moving average is $14.99. Cross Country Healthcare, Inc. has a 12-month low of $9.58 and a 12-month high of $19.25. The firm has a market cap of $594.04 million, a P/E ratio of -361.93, a P/E/G ratio of 3.32 and a beta of 0.44.
Analyst Upgrades and Downgrades
CCRN has been the topic of a number of analyst reports. Truist Financial increased their target price on Cross Country Healthcare from $15.00 to $18.61 and gave the company a "hold" rating in a report on Thursday, December 5th. JMP Securities reiterated a "market perform" rating on shares of Cross Country Healthcare in a report on Thursday, February 6th. Benchmark cut Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. StockNews.com initiated coverage on Cross Country Healthcare in a report on Sunday, February 16th. They set a "hold" rating on the stock. Finally, William Blair cut Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. Six research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Cross Country Healthcare has an average rating of "Hold" and an average target price of $18.54.
Get Our Latest Analysis on CCRN
Cross Country Healthcare Profile
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Stories

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.